Thomas Schmelter Selected Research

sagopilone

6/2013	Prospective, multicenter, randomized, independent-group, open-label phase II study to investigate the efficacy and safety of three regimens with two doses of sagopilone as second-line therapy in patients with stage IIIB or IV non-small-cell lung cancer.
1/2013	A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.
10/2010	Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Schmelter Research Topics

Disease

10	Macular Edema 01/2022 - 08/2012
3	Macular Degeneration (Age-Related Maculopathy) 09/2021 - 01/2019
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2019 - 08/2012
3	Neoplasms (Cancer) 12/2015 - 10/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2015 - 06/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2013 - 10/2010
1	Polypoidal Choroidal Vasculopathy 05/2021
1	Retinal Vein Occlusion 01/2021
1	Choroidal Neovascularization 01/2019
1	Diarrhea 12/2015
1	Exanthema (Rash) 12/2015
1	Fatigue 12/2015
1	Ovarian Cysts (Ovarian Cyst) 05/2015
1	Metrorrhagia (Spotting) 05/2013
1	Hemorrhage 05/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Hyperemia 08/2012
1	Pain (Aches) 08/2012
1	Hypertension (High Blood Pressure) 08/2012
1	Nausea 08/2012
1	Heart Failure 08/2012
1	Eye Hemorrhage 08/2012
1	Breast Neoplasms (Breast Cancer) 10/2010

Drug/Important Bio-Agent (IBA)

13	afliberceptIBA 01/2022 - 08/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017 - 08/2012
3	sagopiloneIBA 06/2013 - 10/2010
3	Epothilones (Epothilone)IBA 06/2013 - 10/2010
2	Retinaldehyde (Retinal)IBA 01/2019 - 08/2012
2	Pharmaceutical PreparationsIBA 01/2019 - 12/2015
2	Levonorgestrel (Plan B)FDA LinkGeneric 05/2015 - 05/2013
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020
1	regorafenibIBA 01/2019
1	Ophthalmic Solutions (Eye Drops)IBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 12/2015
1	Circulating Tumor DNAIBA 12/2015
1	Sorafenib (BAY 43-9006)FDA Link 12/2015
1	Contraceptive Agents (Contraceptives)IBA 05/2015
1	Tranexamic Acid (AMCA)FDA Link 05/2013
1	Mefenamic Acid (Pontal)FDA Link 05/2013
1	Acetylcarnitine (Alcar)IBA 01/2013
1	PlatinumIBA 10/2010

Therapy/Procedure

5	Lasers (Laser) 02/2017 - 08/2012
4	Light Coagulation 02/2017 - 08/2012
2	Therapeutics 02/2017 - 06/2013
1	Photochemotherapy (Photodynamic Therapy) 05/2021
1	Castration 01/2013
1	Drug Therapy (Chemotherapy) 10/2010